Acorda Therapeutics, Inc. (ACOR): Price and Financial Metrics

Acorda Therapeutics, Inc. (ACOR): $0.66

0.22 (-24.86%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add ACOR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#21 of 345

in industry

ACOR Price/Volume Stats

Current price $0.66 52-week high $24.20
Prev. close $0.88 52-week low $0.61
Day low $0.61 Volume 416,900
Day high $0.85 Avg. volume 119,299
50-day MA $11.81 Dividend yield N/A
200-day MA $13.10 Market Cap 820.96K

ACOR Stock Price Chart Interactive Chart >


Acorda Therapeutics, Inc. (ACOR) Company Bio


Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. The company was founded in 1995 and is based in Ardsley, New York.


ACOR Latest News Stream


Event/Time News Detail
Loading, please wait...

ACOR Latest Social Stream


Loading social stream, please wait...

View Full ACOR Social Stream

Latest ACOR News From Around the Web

Below are the latest news stories about ACORDA THERAPEUTICS INC that investors may wish to consider to help them evaluate ACOR as an investment opportunity.

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript

Acorda Therapeutics, Inc. (NASDAQ:ACOR) Q3 2023 Earnings Call Transcript November 13, 2023 Operator: Welcome to Acorda Therapeutics Third Quarter 2023 Financial and Business Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company’s request. […]

Yahoo | November 14, 2023

Acorda Therapeutics Reports Third Quarter 2023 Financial Results

PEARL RIVER, N.Y., November 13, 2023--Acorda Therapeutics Reports Third Quarter 2023 Financial Results

Yahoo | November 13, 2023

Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023

PEARL RIVER, N.Y., November 06, 2023--Acorda Third Quarter 2023 Update: Webcast/Conference Call Scheduled for November 13, 2023

Yahoo | November 6, 2023

Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®

PEARL RIVER, N.Y., November 06, 2023--Acorda Therapeutics Announces Biopas Laboratories Submission to Regulatory Agencies in Six Latin American Countries for Approval of INBRIJA®

Yahoo | November 6, 2023

Acorda Therapeutics (ACOR): A Comprehensive Analysis of Its Market Value

Unveiling the Intrinsic Value of Acorda Therapeutics

Yahoo | August 28, 2023

Read More 'ACOR' Stories Here

ACOR Price Returns

1-mo N/A
3-mo N/A
6-mo -96.03%
1-year -95.96%
3-year -99.09%
5-year -99.92%
YTD -95.63%
2023 -1.59%
2022 -67.92%
2021 -42.28%
2020 -66.17%
2019 -86.91%

Continue Researching ACOR

Here are a few links from around the web to help you further your research on Acorda Therapeutics Inc's stock as an investment opportunity:

Acorda Therapeutics Inc (ACOR) Stock Price | Nasdaq
Acorda Therapeutics Inc (ACOR) Stock Quote, History and News - Yahoo Finance
Acorda Therapeutics Inc (ACOR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!